Từ điển y khoa
Thuật ngữ y khoa chuẩn hóa theo MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
has antineoplastic activity; structure in first source
structure in first source
a hypocretin receptor 2 antagonist
- C5810011-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acidMeSH
a partial RXR agonist; structure in first source
structure in first source
structure in first source
- C5822861-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)ureaMeSH
structure in first source
from Homalomena wendlandii; structure in first source
inhibits both Ron and c-Met kinases; structure in first source
- C5779391-(3-(1H-imidazol-1-yl)propyl)-4-benzoyl-5-(4-bromophenyl)-3-isopropoxy-1H-pyrrol-2(5H)-oneMeSH
antineoplastic agent that inhibits the interaction between p53 and MDM2 protein; structure in first source
antagonist of 5-HT1A, 5-HT1B, and 5-HT1D receptors; structure in first source
structure in first source
inhibits androgen receptor transactivation; structure in first source
has antineoplastic activity; structure in first source
- C5707681-(3-(3-propoxyphenylcarbamoyloxy)-2-hydroxypropyl)-4-(3-trifluoromethylphenyl)piperazinium chlorideMeSH
structure in first source
has antineoplastic activity; structure in first source
- C5782611-(3-(4-chlorophenyl)-5-(3,5-dibromo-2-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanoneMeSH
a BRAF kinase inhibitor; structure in first source
a phospholipase A2alpha inhibitor; structure in first source
a trypanocidal agent that inhibits iron superoxide dismutase; structure in first source
a PET tracer for the norepinephrine transporter; structure in first source
used to derivatize carboxy groups on peptides; structure in first source
structure in first source
structure in first source
a Ca(v)1.3 channel antagonist; structure in fisrt source
inhibits Bloom helicase; structure in first source
- C5692141-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-5-carbonitrileMeSH
inhibits PLA2 and hemorrhagic activities of viper venoms
structure in first source
structure in first source
structure in first source
from an endolichenic fungal strain Scopulariopsis sp.; structure in first source
from Pholidota yunnanensis; has inhibitory activity on nitric oxide production; structure in first source
from Daphne giraldii callus cells; structure in first source
also inhibits mTOR; structure in first source
- C5825431-(4-(1H-pyrazolo(3,4-d)pyrimidin-4-yloxy)phenyl)-3-(4-chloro-3-(trifluoromethyl)phenyl)ureaMeSH
structure in first source
an mGlu5 positive modulator; structure in first source
an aurora kinase inhibitor; structure in first source
structure in first source
an mGluR5 agonist; structure in first source
has antineoplastic activity; structure in first source
structure in first source
for imaging beta-amyloid plaques; structure in first source
structure in first source
structure in first source
- C5731171-(4-(5'-chloro-3,5-dimethyl-2,4'-bipyridin-2'-yl)piperazin-1-yl)-3-(methylsulfonyl)propan-1-oneMeSH
a potent and selective Smoothened antagonist that penetrates the blood-brain barrier; structure in first source
structure in first source
structure in first source
- C5840961-(4-(6-(2-(isopropylsulfonyl)phenylamino)-9H-purin-2-ylamino)-3-ethoxyphenyl)piperidin-4-olMeSH
an MPS1 inhibitor that sensitizes glioblastoma cells to antimitotic drugs; structure in first source
a synthetic alpha-lipoic acid derivative; structure in first source
an antineoplastic agent; structure in first source
structure in first source